Revista Alergia México (Jun 2015)

Prevalence of intolerance to salicylates in patients with nasal polyposis

  • Jaisel Luz Castilla-Rodríguez,
  • María Eugenia Vargas-Camaño,
  • Rodrigo Alberto Rodríguez-Briceño,
  • Jorge Galicia-Tapia,
  • María Isabel Castrejón-Vázquez

DOI
https://doi.org/10.29262/ram.v62i3.101
Journal volume & issue
Vol. 62, no. 3
pp. 202 – 210

Abstract

Read online

Background: Salicylates intolerance is related to alteration in the metabolism of arachidonic acid leading to increased leukotrienes. The condition may be manifested with respiratory, skin or systemic symptoms or associated with sinonasal polyposis. Salicylates are present in anti-inflammatory drugs, cosmetics products and food. Objective: To determine the prevalence of salicylates intolerance in patients with sinonasal polyposis presenting to Clinical Immunology and Allergy and Otolaryngology Service, CMN 20 Noviembre, Mexico City. Material and method: An observational, descriptive, cross sectional study included patients with sinonasal polyposis. The sample size was 49 patients, and variables were compared using STATISTICA 8.0. Results: The prevalence of sinonasal polyposis was 4% of the study group, predominantly in females; only 24% of the population had an ideal weight, the salicylates intolerance prevalence was 53%, and the Samter triad was 31%. Conclusions: Sinonasal polyposis has an inflammatory disease pattern. Its pathophysiology is not yet fully established and in this study was related to obesity and persistent sinusitis. The most feared complication recurrence is associated with salicylates intolerance. The study found a slight increase of recurrence in the group of intolerance, with no statistically significant difference, possibly related to the sample size.

Keywords